Allergan Aesthetics, an AbbVie company
Juvéderm
A family of hyaluronic acid fillers with product-specific formulations and approved treatment areas.
Hyaluronic acid dermal filler familyReviewed 7/30/2026Source recorded
At a glance
| Primary purpose | Product-specific facial augmentation or correction across cheeks, chin, temples, jawline, lips, perioral lines, folds, and infraorbital hollowing. |
|---|---|
| Mechanism | Cross-linked hyaluronic acid gel adds physical volume; rheology, concentration, cross-linking, lidocaine content, approved plane, and intended area differ by product. |
| When results appear | Immediate gel volume, followed by reassessment after injection-related swelling. |
| Typical sessions | Usually one visit per area with possible staged treatment or touch-up; product and volume are individualized. |
| Downtime | Typically limited, but swelling, bruising, tenderness, redness, firmness, and lumps may occur. |
| Longevity | Varies by the specific Juvéderm product, treatment area, amount, and patient; family-wide duration claims are not used. |
| Reversibility | The HA gel may often be reduced with off-label hyaluronidase, but response is product dependent and not guaranteed. |
| Documented risks | Injection-site reactions, lumps or nodules, infection, inflammatory reactions, and rare intravascular injection with necrosis, vision loss, or stroke. |
| Most common disappointment | Choosing by brand family rather than by the exact product and intended area can create an invalid comparison or mismatched outcome. |
| Common marketing misconception | Juvéderm is a portfolio, not a single filler with one set of indications or one longevity. |
| What varies by provider | Specific product, volume, injection plane, anatomy, technique, and management of vascular complications. |
| When this treatment may not be appropriate | When no product in the family is appropriate for the intended area or when filler contraindications or a non-volume problem applies. |
| United States regulatory status | Juvéderm devices are FDA-approved through product-specific PMAs and supplements; the brand family does not have one universal indication. |
| Canadian regulatory status | Health Canada MDALL lists active Class III Juvéderm licences, including family and product-specific records; the exact licensed device and intended use must be checked. |
| Evidence status | High for family composition and product-specific regulatory status; family-wide outcome and duration claims are intentionally avoided. |
Sources
- About the Juvéderm Collectionofficial manufacturer information · manufacturer-primary
- FDA PMA P050047/S052FDA PMA record · regulatory-primary · supports 2 profile fields
- Health Canada MDALL: Allergan Juvéderm licencesHealth Canada MDALL · regulatory-primary
- Juvéderm Collection: Treatment Areas and Important Safety Informationofficial manufacturer safety information · manufacturer-primary · supports 22 profile fields
Related comparisons
See average treatment prices near you
Enter a US ZIP code or Canadian postal code to check our stored estimate for the surrounding market.